Syntermed Receives FDA Clearance for AdreView Tools™

Syntermed's software AdreView Tools, a new application for Emory Cardiac Toolbox, is now FDA cleared and has an expanded indication: first, for the quantitative analysis and display of SPECT AdreViewTM (123I-mIBG) data sets used for evaluation of patients with congestive heart failure, and second, AdreView Tool can be used for the quantitative analysis of SPECT studies.

Full Press Release